Aplicare Antiseptic Chlorhexidine Gluconate
- Manufacturer
- Aplicare, Inc.
- Effective date
- 2010-06-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-05-31 22:25:09
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient
Chlorhexidine Gluconate 2% solution
OTC - PURPOSE SECTION
Purpose
Surgical hand scrub
Healthcare personnel handwash
Patient preoperative skin preparation
Skin wound and general skin cleansing
WARNINGS SECTION
For external use only
OTC - DO NOT USE SECTION
Do not use
- if you are allergic to chlorhexidine gluconate or any other ingredients
- in contact with meninges
- in the genital area
- as a preoperative skin prep of the head or face
OTC - WHEN USING SECTION
When using this product
- keep out of eyes, ears and mouth. May cause serious and permanent eye injury if placed or kept in the eye during surgical procedures or may cause deafness when installed in the middle ear through perforated ear drums.
- if solution should contact these areas, rinse out promptly and thoroughly with water
- wounds which involve more than the superficial layers of the skin should not be routinely treated
- repeated general skin cleansing of large body areas should not be done except when the underlying condition makes it necessary to reduce the bacterial population of the skin
OTC - STOP USE SECTION
Stop use and ask a doctor if irritation, sensitization or allergic reaction occurs. This may be signs of a serious condition.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
Surgical hand scrub
- wet hands and forearms under running water
- scrub for 3 minutes with about 5 ml of product and a wet brush paying close attention to the nails, cuticles and interdigital spaces
- a separate nail cleaner may be used
- rinse thoroughly
- wash for an additional 3 minutes with 5 ml of product and rinse under running water
- dry thoroughly
- wet hands with water
- dispense about 5 ml of product into cupped hands and wash in a vigorous manner for 15 seconds
- rinse and dry thoroughly
- apply product liberally to surgical site and swab for at least 2 minutes
- dry with a sterile towel
- repeat procedure for an additional 2 minutes and dry with a sterile towel
- thoroughly rinse the area to be cleaned with water
- apply the minimum amount of product necessary to cover the skin or wound area and wash gently
- rinse again thoroughly
OTC - QUESTIONS SECTION
Questions or comments?
1-800-760-3236 (Mon.-Fri. 8:30AM - 5:00 PM EST)
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
2% Chlorhexidine Gluconate, 4 oz.
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| CHLORHEXIDINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| bb6d6c68-649d-4e6d-a1f6-603d969c8f68 | Product name | 1 | 20160303 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52380-1274-4 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d728-621f-e053-dbdaa90a74ad | Drug Facts |
| 52380-1274-6 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d728-621f-e053-dbdaa90a74ad | Drug Facts |
| 52380-1274-7 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d728-621f-e053-dbdaa90a74ad | Drug Facts |
| 52380-1274-8 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d728-621f-e053-dbdaa90a74ad | Drug Facts |
| 52380-1274-9 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d728-621f-e053-dbdaa90a74ad | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52380-1274-4 | Aplicare Antiseptic Chlorhexidine Gluconate | 120 g in 1 BOTTLE | SOLUTION | 120 | 3 | |
| 52380-1274-6 | Aplicare Antiseptic Chlorhexidine Gluconate | 480 g in 1 BOTTLE | SOLUTION | 480 | 3 | |
| 52380-1274-7 | Aplicare Antiseptic Chlorhexidine Gluconate | 960 g in 1 BOTTLE | SOLUTION | 960 | 3 | |
| 52380-1274-8 | Aplicare Antiseptic Chlorhexidine Gluconate | 240 g in 1 BOTTLE | SOLUTION | 240 | 3 | |
| 52380-1274-9 | Aplicare Antiseptic Chlorhexidine Gluconate | 3785 g in 1 BOTTLE | SOLUTION | 3785 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 52380-1274 | APLICARE ANTISEPTIC CHLORHEXIDINE GLUCONATE (CHLORHEXIDINE GLUCONATE) SOLUTION [APLICARE, INC.] | 3 | Legacy NDC, 5 package rows | 20100712_6a77ef12-825d-4b37-8c1c-6540bf7970c4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52380-1274-4 | ML - Milliliter | 52380-1274 | 71b9d843-57fc-4cc1-9eba-49b6b6889e63 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Chlorhexidine Gluconate | ACTIVE INGREDIENT | MOR84MUD8E | 3 | |
| Chlorhexidine | ACTIVE MOIETY | R4KO0DY52L | 3 | |
| Anhydrous Citric Acid | INACTIVE INGREDIENT | XF417D3PSL | 3 | |
| Cocamide Diethanolamine | INACTIVE INGREDIENT | 92005F972D | 3 | |
| Hydroxyethyl Cellulose (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | 3 | |
| Isopropyl Alcohol | INACTIVE INGREDIENT | ND2M416302 | 3 | |
| Lauramine Oxide | INACTIVE INGREDIENT | 4F6FC4MI8W | 3 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Products#
Every source-derived product name is available through these pages.
- Aplicare Antiseptic Chlorhexidine Gluconate
- Chlorhexidine Gluconate
- Chlorhexidine
- Anhydrous Citric Acid
- Cocamide Diethanolamine
- Hydroxyethyl Cellulose (140 CPS AT 5%)
- Isopropyl Alcohol
- Lauramine Oxide
- Water
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 52380-1274 | 52380-1274-4, 52380-1274-8, 52380-1274-6, 52380-1274-7, 52380-1274-9 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Chlorhexidine Gluconate | MOR84MUD8E | ACTIB |
| Anhydrous Citric Acid | XF417D3PSL | IACT |
| Cocamide Diethanolamine | 92005F972D | IACT |
| Hydroxyethyl Cellulose (140 CPS AT 5%) | 8136Y38GY5 | IACT |
| Isopropyl Alcohol | ND2M416302 | IACT |
| Lauramine Oxide | 4F6FC4MI8W | IACT |
| Water | 059QF0KO0R | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | CREAM / TOPICAL | 1 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | POWDER, FOR SOLUTION / ORAL | 123 mg | ||
| Cocamide Diethanolamine | COCO DIETHANOLAMIDE | 92005F972D | SPONGE / TOPICAL | 2 %w/w | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / ORAL | 15 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / BUCCAL | 2 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 81 mg | ||
| Lauramine Oxide | LAURAMINE OXIDE | 4F6FC4MI8W | SPONGE / TOPICAL | NA | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | SPONGE / TOPICAL | 4 %w/w | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / NASAL | 5 mg | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | GEL / TOPICAL | 75 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / SUBLINGUAL | 36 mg | ||
| Hydroxyethyl Cellulose (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SUSPENSION / ORAL | 1200 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / BUCCAL | 30 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SHAMPOO / TOPICAL | 0.07 %w/w | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EFFERVESCENT / ORAL | 840 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | GEL / TOPICAL | 3 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / TOPICAL | 0.01 %w/w | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | LOZENGE / TRANSMUCOSAL | 44 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | CONCENTRATE / ORAL | 84 mg | ||
| Cocamide Diethanolamine | COCO DIETHANOLAMIDE | 92005F972D | CREAM / TOPICAL | 30 mg | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | SWAB / TOPICAL | 43.9 %w/w | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 35 mg | ||
| Hydroxyethyl Cellulose (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM, SOLUBLE / BUCCAL | 161 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE / ORAL | 131 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | AEROSOL, FOAM / TOPICAL | 6 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | CONCENTRATE / INTRAVENOUS | ADJ PH | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE / ORAL | 4 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | LIQUID / INTRAVENOUS | 18 mg | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | OIL / TOPICAL | 72 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAMUSCULAR | 101 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / BUCCAL | 9 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / SUBCUTANEOUS | 101 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / ORAL | 3900 mg | ||
| Hydroxyethyl Cellulose (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SYRUP / ORAL | 100 mg/5ml | ||
| Hydroxyethyl Cellulose (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / ORAL | 400 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY, METERED / NASAL | 1.2 mg/1ml | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | SOLUTION / TOPICAL | 40 %w/v | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / TOPICAL | 4.35 %w/v | ||
| Cocamide Diethanolamine | COCO DIETHANOLAMIDE | 92005F972D | SOLUTION / TOPICAL | 2.5 %w/v | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | LOTION / TOPICAL | 211 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / RECTAL | 904 mg | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | OIL / AURICULAR (OTIC) | 6 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | OIL / TOPICAL | 2 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / SUBCUTANEOUS | 25 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 12 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE, LIQUID FILLED / ORAL | 360 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / RESPIRATORY (INHALATION) | 5 mg | ||
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ND2M416302 | GEL, METERED / TOPICAL | 525 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION, EXTENDED RELEASE / ORAL | 62 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EXTENDED RELEASE / ORAL | 312 mg | ||
| Lauramine Oxide | LAURAMINE OXIDE | 4F6FC4MI8W | SOLUTION / TOPICAL | 3.5 %w/v | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | CLOTH / TOPICAL | 4.2 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION, CONCENTRATE / INTRAVENOUS | 60 mg | ||
| Hydroxyethyl Cellulose (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | CAPSULE / ORAL | 20 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | PASTE / ORAL | 26 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAVENOUS | 1152 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 414 mg | ||
| Anhydrous Citric Acid | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / SUBLINGUAL | 11 mg |
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019422-001 | DYNA-HEX 2 | CHLORHEXIDINE GLUCONATE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N019422-001 | DYNA-HEX 2 | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N019422-001 | DYNA-HEX 2 | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N019422-001 | EXIDINE | 2% | SOLUTION / TOPICAL | RLD, RS | 1985-12-17 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f9bac287-2fea-404f-96e7-1c3dd8b8aac3 | 6a77ef12-825d-4b37-8c1c-6540bf7970c4 | 2010-06-09 | Warnings | f9bac287-2fea-404f-96e7-1c3dd8b8aac3 6a77ef12-825d-4b37-8c1c-6540bf7970c4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
